APC and colorectal cancer: It has been reported that peptide inhibitors, such as MAI-108 in Reference [9], disrupt the interaction between ARM and ABR and effectively block the formation of the APC-Asef complex, which provide insights into the development of novel therapeutics toward colorectal cancer.